Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

What On Earth Has Happened To a2 Milk (A2M) and Bellamy’s (BAL) Shares??

It seems a2 Milk Company Ltd (ASX:A2M) shares, Bellamy’s Australia Ltd (ASX:BAL) shares and Bubs Australia Ltd (ASX:BUB) shares have fallen off the radar of ASX investors. 

It seems a2 Milk Company Ltd (ASX: A2M) shares, Bellamy’s Australia Ltd (ASX: BAL) shares and Bubs Australia Ltd (ASX: BUB) shares have fallen off the radar of ASX investors.

About A2, Bellamy’s and Bubs

Bellamy’s, a2 Milk and Bubs are three of the biggest and most popular players in the infant formula market. A2 Milk is by far the largest of the three companies, with a market capitalization of close to $10 billion.

The three companies all rallied from the start of this year and gained a lot of attention, but they seem to have fallen out of favour over the last two months. What happened?

Trade War

What goes on in China has a huge impact on infant formula companies like Bellamy’s and a2 Milk because their valuations are largely based on the potential of the Chinese market. As a result, the infant formula companies almost become a proxy for how fearful investors are of the US-China trade war.

Around three weeks ago, news arrived from China that there could be plans to increase the amount of infant formula produced domestically rather than allowing unlimited imports from companies like a2 Milk and Bellamy’s.

As a result of the trade war fears, a2 Milk shares have fallen 15.7% from their April peak, while Bellamy’s and Bubs have fallen a staggering 32.3% and 39.4% respectively.

The question is, are they now undervalued?

Undervalued or Overvalued?

The share price declines show that investors perceive the trade war as a very real threat to the infant formula companies. Bubs and Bellamy’s, in particular, have proven to be extremely volatile recently.

Personally, the only one of the three companies I would touch right now is a2 Milk. I wrote about this in more depth recently, but basically, a2 Milk is the largest of the three companies and the only one with a significant market share in the Chinese infant formula market (around 5.7%).

If China is serious about cutting imports and boosting domestic supply, the first companies to lose will be the ones that are yet to establish a significant market share — namely, Bellamy’s and Bubs.

While a2 Milk faces a lot of uncertainty, I think it will prove to be the most stable of the three companies.

Ultimately, for growth over the short or medium-term, I’d look away from infant formula and towards one of the companies in the free report below.

[ls_content_block id=”14947″ para=”paragraphs”]

Disclosure: At the time of writing, Max does not own shares in any of the companies mentioned.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content